Trials / Conditions / Stage IVB Bladder Cancer AJCC v8
Stage IVB Bladder Cancer AJCC v8
6 registered clinical trials studyying Stage IVB Bladder Cancer AJCC v8.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | ARID1A and/or KDM6A Mutation and CXCL13 Expression NCT04953104 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progress NCT04902040 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913 | City of Hope Medical Center | — |
| Completed | Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial C NCT03513952 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small NCT03582475 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Active Not Recruiting | Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Loca NCT03601455 | Jonsson Comprehensive Cancer Center | Phase 2 |